Robert E. Phay, Jr.
@Frontier Capital Management Co Llc
Latest period2024 - Q3ReportedManaged Assets$10.624BTotal holdings281
Assets growth rate5.2%Assets growth rate (2-Q avg)-0.21%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Frontier Capital Management Co Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 281 positions.
Assets under management
The assets under management (AUM) of Frontier Capital Management Co Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 10.624B in assets, with a quarterly growth rate of 5.2% and a 2-quarter average growth rate of -0.21%. The portfolio is managed by Robert E. Phay, Jr., and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
SITCSite Ctrs Corp
| 0.43% | $44.932M 742,670 shares@ $60.5 avg price | New Position |
EPRTEssential Pptys Rlty Tr Inc
| 0.38% | $39.741M 1.164M shares@ $34.16 avg price | New Position |
ROLRollins Inc
| 0.35% | $36.499M 721,611 shares@ $50.58 avg price | New Position |
LWLamb Weston Hldgs Inc
| 0.3% | $31.36M 484,402 shares@ $64.74 avg price | New Position |
COINCoinbase Global Inc
| 0.26% | $27.179M 152,546 shares@ $178.18 avg price | New Position |
LTHLife Time Group Holdings Inc
| 0.2% | $21.138M 865,606 shares@ $24.43 avg price | New Position |
EBCEastern Bankshares Inc
| 0.2% | $20.603M 1.257M shares@ $16.4 avg price | New Position |
KYMRKymera Therapeutics Inc
| 0.18% | $18.566M 392,263 shares@ $47.34 avg price | New Position |
APGEApogee Therapeutics Inc
| 0.18% | $18.287M 311,316 shares@ $58.75 avg price | New Position |
KROSKeros Therapeutics Inc
| 0.16% | $16.694M 287,484 shares@ $58.08 avg price | New Position |